A detailed history of Seascape Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Seascape Capital Management holds 32,989 shares of EW stock, worth $2.24 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
32,989
Previous 32,815 0.53%
Holding current value
$2.24 Million
Previous $3.03 Million 28.18%
% of portfolio
0.78%
Previous 1.13%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$59.7 - $93.78 $10,387 - $16,317
174 Added 0.53%
32,989 $2.18 Million
Q2 2024

Jul 30, 2024

BUY
$84.3 - $94.31 $139,769 - $156,365
1,658 Added 5.32%
32,815 $3.03 Million
Q1 2024

Apr 29, 2024

BUY
$72.54 - $95.56 $245,983 - $324,043
3,391 Added 12.21%
31,157 $2.98 Million
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $10,490 - $13,219
170 Added 0.62%
27,766 $2.12 Million
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $41,845 - $56,401
604 Added 2.24%
27,596 $1.91 Million
Q2 2023

Aug 04, 2023

SELL
$81.41 - $94.33 $41,274 - $47,825
-507 Reduced 1.84%
26,992 $2.55 Million
Q1 2023

May 01, 2023

SELL
$74.26 - $84.51 $4,307 - $4,901
-58 Reduced 0.21%
27,499 $2.28 Million
Q4 2022

Jan 31, 2023

BUY
$68.3 - $87.44 $31,418 - $40,222
460 Added 1.7%
27,557 $2.06 Million
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $27,429 - $35,727
333 Added 1.24%
27,097 $2.24 Million
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $5,882 - $8,722
68 Added 0.25%
26,764 $2.55 Million
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $98,493 - $123,976
-966 Reduced 3.49%
26,696 $3.14 Million
Q4 2021

Jan 27, 2022

BUY
$106.37 - $130.68 $24,252 - $29,795
228 Added 0.83%
27,662 $3.58 Million
Q3 2021

Nov 05, 2021

BUY
$102.91 - $122.75 $30,152 - $35,965
293 Added 1.08%
27,434 $3.11 Million
Q2 2021

Aug 04, 2021

BUY
$83.84 - $104.76 $27,415 - $34,256
327 Added 1.22%
27,141 $2.27 Million
Q2 2021

Aug 04, 2021

SELL
$83.84 - $104.76 $27,415 - $34,256
-327 Reduced 1.2%
26,814 $2.78 Million
Q1 2021

Apr 29, 2021

SELL
$78.68 - $90.67 $207,636 - $239,278
-2,639 Reduced 8.86%
27,141 $2.27 Million
Q4 2020

Jan 28, 2021

SELL
$71.69 - $91.23 $6,452 - $8,210
-90 Reduced 0.3%
29,780 $2.72 Million
Q3 2020

Nov 09, 2020

SELL
$67.19 - $87.44 $25,800 - $33,576
-384 Reduced 1.27%
29,870 $2.38 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $1.74 Million - $2.33 Million
30,254 New
30,254 $2.09 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Seascape Capital Management Portfolio

Follow Seascape Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seascape Capital Management with notifications on news.